Apollo Medical(US:AMEH)2023-11-08 03:10Financial Data and Key Metrics Changes - Revenue for Q3 2023 was $348 million, representing a 10% increase compared to the prior year period [7][21] - Capitated revenue grew by approximately 34% to around $306 million [7][21] - Adjusted EBITDA was $52 million, down from $57.1 million year-over-year, with an adjusted EBITDA margin of around 15% [7][23] - Net income attributable to ApolloMed was $22.1 million, compared to $23.2 million in the prior year [24] Business Line Data and Key Metrics Changes - The company operates in three segments: Care Partners, Care Delivery, and Care Enablement, all of which experienced growth [7] - Care Enablement membership decreased to approximately 900,000 due to a client ending their contract, while the Care Partners segment is expected to grow by approximately 200,000 members with the acquisition of Community Family Care [22] Market Data and Key Metrics Changes - The company serves approximately 900,000 members across its segments, with over 90% of revenue related to value-based care [16][21] - The company has established partnerships with five provider groups in 2023, enhancing its geographic footprint and service capabilities [15] Company Strategy and Development Direction - ApolloMed announced its intent to acquire Community Family Care Medical Group, which will enhance its capabilities in managing care for Medicaid populations [8][19] - The company aims to leverage synergies from the acquisition to manage total cost of care more effectively and expand access to high-quality care [9][10] - The strategic partnership with Wider Circle aims to provide comprehensive patient-centered care for Medicaid members with complex needs [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustained profitability and growth, despite headwinds from Medicaid redetermination [17][25] - The company narrowed its revenue guidance for the full year to between $1.34 billion and $1.39 billion, citing small headwinds impacting membership [25] - Management remains optimistic about future growth, expecting adjusted EBITDA to be between $135 million and $150 million for the year [25] Other Important Information - The company announced a $300 million oversubscribed term loan, increasing its total facility to $700 million, which will be used for future M&A transactions and share buybacks [20] - The acquisition of Community Family Care is expected to generate approximately $190 million in revenue and $25 million in adjusted EBITDA in its first year [18][19] Q&A Session Summary Question: What is driving the recent momentum in partnerships and acquisitions? - Management indicated that the partnerships have been in development throughout the year and are now coming to fruition [29] Question: Are the Restricted Knox-Keene licenses different for Medicaid and Commercial? - Yes, separate licenses are required for each line of business, which will accelerate the ability to take on full risk for Medicaid populations [32] Question: What is the impact of Medicaid redeterminations on revenue? - The net margin impact from Medicaid redeterminations is minimal, estimated at $1 million to $1.5 million annually, with a revenue impact of $5 million to $10 million for 2024 [46] Question: How does the company expect to manage costs and utilization trends? - Management noted stable utilization trends and attributed this to their unique care model, which focuses on access and quality [39] Question: What are the expectations for Medicare premiums in 2024? - Management does not foresee significant headwinds in Medicare premiums and expects to maintain solid contracts with payer partners [61]